Dr. Fox is a highly accomplished professional with over two decades of experience in the fields of data science, computational biology, protein, metabolic, and genome engineering. He possesses extensive knowledge and expertise in directed evolution, biostatistics, computational analyses, and machine learning. He is widely recognized and respected for his contributions to the development of machine learning and data science-driven tools and strategies for the rapid forward engineering of biological systems. Currently serving as SVP Synthetic Biology Products at Inscripta, Dr. Fox is leading the development of a revolutionary, full-stack, next-generation bio foundry. The GenoScaler™ platform is based on novel, massively parallel molecular biology workflows, automated HTP phenotyping & genotyping technologies, and a fully integrated software, analysis, and prediction system that radically reduces the time, cost, and risk associated with the development of sustainable, high value biomanufacturing processes. Prior to his current role, Dr. Fox held key leadership positions at Intrexon, DuPont Pioneer, and Codexis. He earned a Ph.D. in nuclear engineering and worked for various Fortune 500 companies and the U.S. Navy before transitioning to the fields of bioengineering, data science, and machine intelligence.